Rectovaginal septum endometriosis:an immunohistochemical analysis of 62 cases

In Vivo

Volumn 23, Issue 3, 2009, Pages 459-464

  Signorile, Pietro G ^a   Campioni, Mara ^a,b   Vincenzi, Bruno ^c   D'avino, Alfredo ^b   Baldi, Alfonso ^a,b  

^a lFondazione Italiana Endometriosi   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

CD34; Endometriosis; Immunohistochemistry; Oestrogen; Progesterone; S100

Indexed keywords

CD34 ANTIGEN; ESTROGEN; PROGESTERONE RECEPTOR; PROTEIN S 100;

ARTICLE; CELL PROLIFERATION; CORRELATION COEFFICIENT; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NERVE FIBER; PROTEIN EXPRESSION; RECTOVAGINAL SEPTUM; VAGINA; VASCULARIZATION;

EID: 65349151773     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Baldi A,Campioni M and Signorile PG: Endometriosis: pathogenesis, diagnosis, therapy and association with cancer. Oncol Reports 19: 843-846, 2008.
2. Giudice LC and Kao LC: Endometriosis. The Lancet 364: 1789-1799, 2004.
3. Houston DE: Evidence for the risk of pelvic endometriosis by age, race, and socioeconomic status. Epidemiol Rev 6: 167-191, 1984.
4. Koninckx PR and Martin D: Treatment of deeply infiltrating endometriosis. Curr Opin Obstet Gynecol 6: 231-234, 1994.
5. Konicckx PR, Meuleman C, Demeyere S, Lesaffre E and Cornillie FJ: Suggestive evidence that pelvic endoemtriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertile Steril 55: 759-765,1991.
6. Fauconnier A and Chapron C: Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update 11: 527-534, 2005.
7. Anaf V, Chapron C, El Nakadi I, De Moor V, Simonart T and Noel JC: Pain, mast cells, and nerves in peritoneal, ovarian, and deep oinfiltrating endometriosis. Fertil Steril 86: 1336-1343, 2006.
8. Dubuisson JB and Chapron C: Classification of endometriosis. The need for modification. Hum Reprod 9: 2214-2216, 1994.
9. Howell RJ, Dowsett M and Edmonds DK: Oestrogen and progesterone receptors in endometriosis: heterogeneity of different sites. Human Reprod 9: 1752-1758, 1994.
10. Jones RK, Bulmer JN and Searle RF: Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Human Reprod 10: 3272-3279, 1995
11. Sampson JA: Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obst Gynecol 14: 442-469, 1927.
12. Nap AW, Groothuis PG, Demir AY, Evers JL and Dunselman GA: Pathogenesis of endometriosis. Bet Pract Res Clin Obstet Gynaecol 18: 233-244, 2004.
13. Brosens I: Endometriosis and the outcome of in vitro fertilization. Fertil Steril 81: 1198-1200, 2004.
14. Nisolle M and Donnez J: Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 68: 585-595,1997.
15. Leibovic DI, Mueller MD and Taylor RN: Immunobiology of endometriosis. Fertil Steril 75: 1-10, 2001.
16. Kennedy S, Bennet S and Weeks DE: Affected sib-pair analysis in endometriosis. Human Reprod Update 7: 411-418, 2001.
17. Kennedy SH: Genetics of endometriosis, a review of the positional cloning approaches. Sem Reprod Med 21: 111-118, 2003.
18. Bischoff FZ, Marquez-Do DD, Carson SA, Buster JE and Simpson JL: NAT2 and GST Ml DNA polymorphism, increased GSTM1 (active) genotype in endometriosis. Fertil Steril 77: S17,2002.
19. Nakago S, Hadfield RM, Zondervan KT, Mardon H, Manek S, Weeks DE, Barlow D and Kennedy S: Association between endometriosis and N-acetyl transferase polymorphisms in a UK population. Mol Hum Reprod 7: 1079-1082, 2001.
20. Baxter SW, Thomas EJ and Campbell IG: GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis 22: 63-65, 2001.
21. Zondervan KT, Cadon LR and Kennedy S: What makes a good case control study? Design issues for complex traits such as endometriosis. Hum Reprod 17: 1415-1423, 2002.
22. Donnez J, Nisolle M and Smoes P: Peritoneal endometriosis and endometriotic nodules of the rectovaginal septum are two different entities. Fertil Steril 66: 362-368, 1996.
23. Donnez J, Nisolle M, Gillerot S, Smets M, Bassil S and Casanas-Roux F: Rectovaginal septum adenomyotic nodules:a series of 500 cases. Br J Obstet Gynaecol 104: 1014-1018,1997.
24. Chapron C, Fauconnier A, Dubuisson JB, Barakat H, Vieira M Breart G: Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease. Hum Reprod 18: 760-766, 2003.
25. Howell RJ, Dowsett M and Edmonds DK: Oestrogen and progesterone receptors in endometriosis: heterogeneity of different sites. Hum Reprod 9: 1752-1758, 1995.
26. Jones RK, Bulmer JN and Searle RF: Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Hum Reprod 10: 3272-3279, 1995.
27. Zeitoun K, Takayama K, Michael MD and Bulun SE: Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol Endocrinol 13: 239-253,1999.
28. Machado DE, Abrao MS, Berardo PT, Takiya CM and Nasciutti LE: Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril 90: 148-155,2008.